Key result
Degenerative mitral stenosis carries >50% five-year mortality and frequently presents as mixed or multivalvular disease.
This review highlights the high mortality of degenerative mitral stenosis and the critical role of multimodality imaging in its assessment and management.
Degenerative mitral stenosis warrants clinical vigilance for poor outcomes; leaves open optimal multimodality imaging strategies in mixed valvular disease.
•DMS has a high morbidity and a 5-year mortality rate of >50%.•DMS frequently occurs as mixed mitral disease as well as multivalvular disease.•Assessment of severity requires use of TTE, TEE, and stress echocardiography.•CT is used for periprocedural planning.•Treatment can be surgical or transcatheter.
No takes yet. Share an insight, caveat, or question.
Lamberg et al. (2023) studied this question. Degenerative mitral stenosis carries a high morbidity and a 5-year mortality rate exceeding 50%, frequently presenting as mixed mitral or multivalvular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: